Literature DB >> 17436001

Catastrophic antiphospholipid syndrome presented with severe hypertension, adult respiratory distress syndrome and unilateral adrenal haemorrhagic infarction.

Ioannis Starakis1, Elias Mazokopakis, Dimitris Siagris, Stamatis Liossis, Chrysoula Karatza, Andrew Antonopoulos.   

Abstract

We are reporting a case of catastrophic antiphospholipid syndrome (CAPS) in an adult female manifested with severe hypertension followed by adrenal haemorrhagic infarction and adult respiratory distress syndrome. Adrenal involvement appears to be exceedingly high in CAPS and adult respiratory distress syndrome (ARDS) is the prevailing pulmonary manifestation in this condition, compared with these impediments in patients with simple antiphospholipid syndrome (APS). Even though the above manifestations are well recognized, their combination as an initial presentation of CAPS is uncommon.

Entities:  

Mesh:

Year:  2007        PMID: 17436001     DOI: 10.1007/s00296-007-0348-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   3.580


  17 in total

1.  Catastrophic antiphospholipid syndrome: response to repeated plasmapheresis over three years.

Authors:  C M Neuwelt; D I Daikh; J A Linfoot; D A Pfister; R G Young; R L Webb; S S London; R A Asherson
Journal:  Arthritis Rheum       Date:  1997-08

2.  A case of primary antiphospholipid antibody syndrome with acute renal failure showing thrombotic microangiopathy.

Authors:  S Sakaguchi; K Kitazawa; M Watanabe; K Mukai; D Totsuka; T Shibata; T Sugisaki
Journal:  Am J Nephrol       Date:  1999       Impact factor: 3.754

Review 3.  Pathology and pathogenesis of vascular injury in systemic lupus erythematosus. Interactions of inflammatory cells and activated endothelium.

Authors:  H M Belmont; S B Abramson; J T Lie
Journal:  Arthritis Rheum       Date:  1996-01

Review 4.  Molecular mimicry between host and pathogen: examples from parasites and implication.

Authors:  M Abu-Shakra; D Buskila; Y Shoenfeld
Journal:  Immunol Lett       Date:  1999-04-01       Impact factor: 3.685

5.  The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome.

Authors:  J Pugin; G Verghese; M C Widmer; M A Matthay
Journal:  Crit Care Med       Date:  1999-02       Impact factor: 7.598

6.  Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients.

Authors:  R A Asherson; G Espinosa; R Cervera; J A Gómez-Puerta; J Musuruana; S Bucciarelli; M Ramos-Casals; A L Martínez-González; M Ingelmo; J C Reverter; J Font; D A Triplett
Journal:  Ann Rheum Dis       Date:  2005-06       Impact factor: 19.103

7.  Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome.

Authors:  R Cervera; J Font; J A Gómez-Puerta; G Espinosa; M Cucho; S Bucciarelli; M Ramos-Casals; M Ingelmo; J-C Piette; Y Shoenfeld; R A Asherson
Journal:  Ann Rheum Dis       Date:  2005-02-11       Impact factor: 19.103

8.  Treatment of catastrophic antiphospholipid syndrome with defibrotide, a proposed vascular endothelial cell modulator.

Authors:  Arsinur Burcoglu-O'Ral; Doruk Erkan; Ronald Asherson
Journal:  J Rheumatol       Date:  2002-09       Impact factor: 4.666

9.  High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome.

Authors:  S Chollet-Martin; P Montravers; C Gibert; C Elbim; J M Desmonts; J Y Fagon; M A Gougerot-Pocidalo
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

10.  Malignant hypertension in antiphospholipid syndrome without overt lupus nephritis.

Authors:  P Cacoub; B Wechsler; J C Piette; H Beaufils; G Herreman; O Bletry; P Godeau
Journal:  Clin Exp Rheumatol       Date:  1993 Sep-Oct       Impact factor: 4.473

View more
  3 in total

Review 1.  Catastrophic APS in the context of other thrombotic microangiopathies.

Authors:  Ignasi Rodríguez-Pintó; Gerard Espinosa; Ricard Cervera
Journal:  Curr Rheumatol Rep       Date:  2015-01       Impact factor: 4.592

2.  Catastrophic antiphospholipid syndrome presented with abdominal, pulmonary, and bone marrow complications.

Authors:  Badira F Makhoul; Ludmila Guralnik; Zaher S Azzam
Journal:  Rheumatol Int       Date:  2009-05-18       Impact factor: 2.631

3.  Transient pulmonary edema following adrenal infarction in a patient with primary anti-phospholipid syndrome.

Authors:  K Ozawa; K Tazawa; D Kishida; K Fukushima; M Matsuda; S Ikeda
Journal:  Clin Med Insights Case Rep       Date:  2012-12-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.